Bone metabolism in periand postmenopausal women with type 1 diabetes mellitus


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Aim. To estimate the effect of type 1 diabetes mellitus on bone mineral density and bone metabolism parameters in women; determ ine the direction of changes in serum bone remodeling markers and BMD in the peri- and post-menopausal women with this disease. Material and methods. The study comprised 57peri- and post-menopausal women with type 1diabetes (study group) and 43 women in the control group. Diagnostic evaluation included analysis of BMD using DXA and expressed as T-score, and serum bone remodeling markers (ALP, P1NP and b-CTx). Results. The findings showed the inconsistency of changes in bone remodeling in patients with type 1 diabetes mellitus (35.5% and 16.6%, p <0.001) with a predominant change in bone formation. The duration of diabetes had a positive correlation with serum b-CTXconcentration (r = 0.349, p = 0.008). A negative correlation was found between the change in T-score at the lumbar spine and the duration of diabetes (r = -0.239, p = 0.03). There was a statistically signif icant correlation between T-score at the lumbar spine and serum b-CTX level (r = -0.452, p = 0.002). Conclusion. The findings of this study suggest that changes in bone metabolism in the majority of patients are associated with bone formation inhibition and, to a much lesser extent, bone resorption accelerating during the late perimenopause, continuing at similar rates in the early years of postmenopause, and decreasing bone loss later.

全文:

受限制的访问

作者简介

Sain Safarova

Azerbaijan Medical University

Email: sainsafarova@gmail.com
MD, associate professor of the Department of Internal Diseases III, medical-prophylactic faculty II

参考

  1. Vestergaard P., Rejnmark L., Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif. Tissue Int. 2009; 84(1): 45-55.
  2. Pramojanee S.N., Phimphilai M., Chattipakorn N., Chattipakorn S.C. Possible roles of insulin signaling in osteoblasts. Endocr. Res. 2014; 39(4): 144-51.
  3. Соловьёва-Савоярова Г.Е., Дрожжина В.А. Эстрогены и некариозные поражения зубов. СПб.: СЗГМУ им. И.И. Мечникова; 2012.
  4. Farr J.N., Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016; 82: 28-34.
  5. Hough FS., Pierroz D.D., Cooper C., Ferrari S.L.; IOF CSA Bone and Diabetes Working Group. Mechanisms in endocrinology: mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur. J. Endocrinol. 2016; 174(4): R127-38.
  6. AL-Hariri M. Sweet bones: the pathogenesis of bone alteration in diabetes. J. Diabetes Res. 2016; 2016: ID 6969040.
  7. Starup-Linde J., Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - a systematic review. Bone. 2016; 82: 69-78.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2018
##common.cookie##